ACM
VIR icon

Aquatic Capital Management’s Vir Biotechnology VIR Stock Holding History

Aquatic Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$675K Buy
+75,301
New +$600K 0.02% 662
2024
Q3 		– Sell
-5,600
Closed -$49.8K – 1569
2024
Q2 		$49.8K Buy
5,600
+4,300
+331% +$41.2K ﹤0.01% 1015
2024
Q1 		$13.2K Sell
1,300
-1,800
-58% -$18.3K ﹤0.01% 1127
2023
Q4 		$31K Buy
+3,100
New +$28.3K ﹤0.01% 1180
2022
Q4 		– Sell
-18,600
Closed -$359K – 1862
2022
Q3 		$359K Buy
+18,600
New +$473K 0.04% 485
2022
Q2 		– Sell
-1,200
Closed -$31K – 1587
2022
Q1 		$31K Buy
+1,200
New +$35.6K 0.05% 387

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Aquatic Capital Management's VIR Position: Q1 2026 in Review

Aquatic Capital Management opened a new position in Vir Biotechnology (VIR) in Q1 2026: 75,301 shares worth $675K. The stake represents 0.02% of the portfolio and ranks #662 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in VIR as recently as Q2 2024.

Aquatic Capital Management first reported a position in VIR in Q1 2022 and has held it in 6 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Aquatic Capital Management held 75,301 shares of Vir Biotechnology worth $675K as of Q1 2026.
  • Vir Biotechnology was a new Aquatic Capital Management position in Q1 2026.
  • Vir Biotechnology made up 0.02% of Aquatic Capital Management's portfolio in Q1 2026, its #662 holding.
  • Aquatic Capital Management first reported a position in Vir Biotechnology in Q1 2022 and has held it in 6 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.